Acute and chronic effects of captopril therapy in patients with refractory heart failure.

Abstract

British Journal of Clinical PharmacologyVolume 14, Issue S2 p. 153S-159S Free Access Acute and chronic effects of captopril therapy in patients with refractory heart failure. WF Walsh, WF WalshSearch for more papers by this authorCL Lee, CL LeeSearch for more papers by this author WF Walsh, WF WalshSearch for more papers by this authorCL Lee, CL LeeSearch for more papers by this author First published: April 1982 https://doi.org/10.1111/j.1365-2125.1982.tb02072.xAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat References ADER, R., CHATTERJEE, K., PORTS, T., BRUNDAGE, B., HIRAMATSU, B. & PARMLEY, W. (1980). Immediate and sustained haemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Circulation, 61, 931– 937. COHN, J.N. (1973). Vasodilator therapy for heart failure: the influence of impedance on left ventricular performance. Circulation, 48, 5. DAVIS, R., RIBNER, H.S., KEUNG, E., SONNENBLICK, E.H. & LeJEMTEL, T.H. (1979). Treatment of congestive heart failure with captopril, an oral inhibitor of angiotensin converting enzyme. N. Engl. J. Med., 301, 117– 121. DZAU, V.J., COLUCCI, W.S., WILLIAMS, G.H., CURFMAN, G., MEGGS, L. & HOLLENBERG, N. (1980). Sustained effectiveness of converting enzyme inhibitor in patients with severe congestive heart failure. N. Engl. J. Med., 302, 1373– 1379. FRANCIOSA, J. (1982). Effectiveness of long term vasodilator administration in treatment of chronic left ventricular failure. Prog. Cardiovasc. Dis., 1A, 319– 330. MASSIE, B., PORTS, T., CHATTERJEE, K. PARMLEY, W., OSTLAND, J., O'YOUNG, J. & HAUGHOM, F. (1981). Long term vasodilator therapy for heart failure: Clinical response and its relation to haemodynamic measurements. Circulation, 63, 269. PACKER, M., MELLER, J., GORLIN, R. & HERMAN, M.V. (1979). Haemodynamic and clinical tachyphylaxis to prazosin mediated afterload reduction in patients with severe chronic congestive heart failure. Circulation, 59, 531– 539. PACKER, M., MELLER, J., MEDINA, N., YUSHAK, M. & GORLIN, R. (1982). Haemodynamic characterisation of tolerance to long term hydralazine therapy in severe chronic heart failure. N. Engl. J. Med., 306, 57– 62. PACKER, M. & LeJEMTEL, T.H. (1982). Physiologic and pharmacologic determinants of vasodilator response: A conceptual framework for rational drug therapy for chronic heart failure. Prog. Cardiovas. Dis., 24, 275– 292. WALSH, W.F. & GREENBERG, B.H. (1981). Results of long term vasodilator therapy in patients with refractory congestive heart failure. Circulation, 64, 499– 505. Volume14, IssueS2April 1982Pages 153S-159S ReferencesRelatedInformation